Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03595449 · ClinicalTrials.gov registry record · Phase 4
Lidocaine Jelly for Pain Control During Mohs Surgery
A Phase 4 study of Pain and Satisfaction, Consumer, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 4
- Development phase
- 233
- Enrollment target
- 1
- Study location
NCT03595449 is a Phase 4 study of Pain and Satisfaction, Consumer that has completed, run by Mayo Clinic. The registered enrollment target is 233 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (23% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03595449, a Phase 4 study of Pain and Satisfaction, Consumer, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 233 participants
- Enrollment target
- 1
- Study location
Study Summary
Does the use of lidocaine jelly during Mohs surgery on the nose decrease the total amount of lidocaine used during surgery. Does patient satisfaction improve when lidocaine jelly is used during Mohs surgery of the nose?
Conditions Studied
Interventions
- DRUG Surgilube
- DRUG Lidocaine jelly
Study Locations (1)
Arizona
- Mayo Clinic in Arizona - Scottsdale
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 233 participants |
| Start Date | 2018-08-13 |
| Est. Completion | 2020-08-31 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03595449
The ClinicalTrials.gov registry entry for NCT03595449 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 233 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 304-participant average among 374 other Pain trials with a reported enrollment target (23% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Pain appearing as the primary indexed condition, and to 2 interventions - of which Surgilube is the first listed.
NCT03595449 reports 1 study location spanning 1 distinct geographic area - top geographies include Arizona.
Frequently Asked Questions
What is clinical trial NCT03595449 about?
NCT03595449 is a clinical study titled "Lidocaine Jelly for Pain Control During Mohs Surgery". Does the use of lidocaine jelly during Mohs surgery on the nose decrease the total amount of lidocaine used during surgery. Does patient satisfaction improve when lidocaine jelly is used during Mohs surgery of the nose?
What is the current status of trial NCT03595449?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 233 participants. The study started on 2018-08-13. Estimated completion is 2020-08-31.
What conditions does trial NCT03595449 study?
This clinical trial studies the following conditions: Pain, Satisfaction, Consumer.
What interventions are being tested in trial NCT03595449?
The interventions under investigation include: Surgilube (DRUG), Lidocaine jelly (DRUG).
Who is sponsoring clinical trial NCT03595449?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03595449 being conducted?
This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Effect of Magnesium on Neuromonitoring
RECRUITING · Phase 4
-
Low-Dose Ketamine Infusion During Burn Wound Care
RECRUITING · Phase 4
-
Optimizing Perioperative Analgesia to Lower Pain Following Cleft Palate Surgery
RECRUITING · Phase 4
-
Optimizing Pain Control in Transurethral Resection of the Prostate
RECRUITING · Phase 4
-
Low-dose Buccal Buprenorphine: Relative Abuse Potential and Analgesia
RECRUITING · Phase 4
-
Regional Blocks for Lateral Condyle Fractures
RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.